Yunnan Hansu Biotechnology Co., Ltd.
Yunnan Hansu Biotechnology Co., Ltd., commonly referred to as Hansu Biotech, is a leading player in the biotechnology sector, headquartered in China. Established in 2015, the company has rapidly expanded its operations across major regions in Asia, focusing on innovative solutions in the fields of health and wellness. Specialising in the development and production of high-quality CBD products, Hansu Biotech stands out for its commitment to sustainability and rigorous quality control. Their core offerings include CBD oils, edibles, and topical applications, all crafted to meet the diverse needs of consumers seeking natural alternatives. With a strong market position, Hansu Biotech has garnered recognition for its pioneering research and development efforts, positioning itself as a trusted name in the rapidly evolving CBD industry.
DitchCarbon Score
How does Yunnan Hansu Biotechnology Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Yunnan Hansu Biotechnology Co., Ltd.'s score of 12 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Yunnan Hansu Biotechnology Co., Ltd.'s reported carbon emissions
Yunnan Hansu Biotechnology Co., Ltd., headquartered in China, reported a total carbon emissions figure of approximately 66,810 kg CO2e for the year 2020. This total includes about 63,320 kg CO2e from Scope 2 emissions and approximately 3,490 kg CO2e from Scope 3 emissions. Notably, there are no reported emissions for Scope 1. Despite the emissions data available, the company has not disclosed any specific reduction targets or initiatives aimed at decreasing its carbon footprint. Furthermore, there are no commitments to the Science Based Targets initiative (SBTi) or other climate pledges outlined in the provided information. Yunnan Hansu Biotechnology's emissions intensity metrics, such as electricity consumption, remain unspecified, indicating a potential area for improvement in transparency regarding their environmental impact. As the company continues to operate within the biotechnology sector, addressing carbon emissions and establishing clear climate commitments will be essential for aligning with global sustainability goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Get Started| 2020 | |
|---|---|
| Scope 1 | - |
| Scope 2 | 63,320 |
| Scope 3 | 3,490 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Yunnan Hansu Biotechnology Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
